CDI Revenue and Competitors
Estimated Revenue & Valuation
- CDI's estimated annual revenue is currently $15M per year.
- CDI's estimated revenue per employee is $34,014
Employee Data
- CDI has 441 Employees.
- CDI grew their employee count by 0% last year.
CDI Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $35M | 218 | 34% | N/A | N/A |
#2 | $15M | 93 | 29% | N/A | N/A |
#3 | $35M | 359 | 18% | $33.9M | N/A |
#4 | $750M | 19904 | 0% | N/A | N/A |
#5 | $15M | 83 | 5% | N/A | N/A |
#6 | $7.5M | 32 | -9% | N/A | N/A |
#7 | $7.5M | 115 | 15% | N/A | N/A |
#8 | $7.5M | 54 | 10% | N/A | N/A |
#9 | $7.5M | 76 | -8% | N/A | N/A |
#10 | N/A | 1365 | 18% | N/A | N/A |
What Is CDI?
A non-profit organization present in 13 countries, that transforms lives and strengthens low-income communities by empowering people with ICTs.
keywords:N/AN/A
Total Funding
441
Number of Employees
$15M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CDI News
2022-04-17 - CDI Full vs CDI Lite: What's new in Contexts and Dependency Injection 4.0
Previously, the CDI spec included a CDI Core part. That was the basis for the CDI SE and CDI EE implementations. But in 4.0, the CDI Core was...
2022-04-13 - Continuous Enteral Vancomycin Infusion in ICU Patients With ...
CDI is the leading cause of diarrhea in hospitalized patients and a significant health care-associated infection that is associated with a...
2022-04-06 - Continuous Enteral Vancomycin Helpful in Cases of Severe ...
Continuous enteral vancomycin can be an effective treatment patients with severe Clostridioides difficile infection (CDI), according to a...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $148.8M | 441 | 7% | N/A |
#2 | $148.8M | 441 | 7% | N/A |
#3 | $95.9M | 441 | 1% | N/A |
#4 | $125.1M | 441 | 66% | N/A |
#5 | $79.9M | 441 | -1% | N/A |